Zeke Capital Advisors, LLC Catalent, Inc. Transaction History

Zeke Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $48,191 - $75,324	666 Added 10.9%	6,777 $490,000
Q2 2022 Aug 09, 2022	BUY	$87.2 - $114.05 $47,262 - $61,815	542 Added 9.73%	6,111 $656,000
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $524,544 - $693,284	5,569 New	5,569 $618,000
Q4 2018 Feb 11, 2019	SELL	$29.95 - $46.34 $589,955 - $912,805	-19,698 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$40.12 - $45.55 $508,200 - $576,981	12,667 Added 180.16%	19,698 $897,000
Q1 2018 May 03, 2018	BUY	$39.4 - $47.39 $277,021 - $333,199	7,031 New	7,031 $289,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.